Latest Story

Latest Posts

  • Pharma
  • June 5, 2025
  • 72 views
Patanjali and AIIMS Bhopal partner to develop holistic treatment solutions

AIIMS Bhopal has taken a historic step toward integrating Indian systems of medicine with modern healthcare through a Memorandum of Understanding (MoU) signed with the Patanjali Research Foundation Trust. This…

  • Pharma
  • June 5, 2025
  • 87 views
NPPA fixes retail prices for 41 drug combinations, including empagliflozin

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 41 drug combinations, including 18 variants of the off-patent diabetes drug empagliflozin, originally developed by German pharmaceutical company…

  • Pharma
  • June 4, 2025
  • 283 views
Drug Inspector Dismissed After Rs 4 Crore Cash Found in Sacks; Linked to Illegal Sale of Pharmacist Degrees

Patna: A drug inspector in Bihar has been dismissed from service following the discovery of Rs 4 crore in cash during a raid in 2022, along with evidence of extensive corruption,…

  • Pharma
  • June 4, 2025
  • 155 views
Delhi Crime branch cracks down on fake cancer drug sellers, arrest six individuals

New Delhi :  The Crime Branch of Delhi Police has busted a racket selling spurious cancer medicines and injections, arresting six individuals and seizing several high-value spurious cancer drugs on…

  • Pharma
  • June 4, 2025
  • 83 views
‘Made in India’ Surgical Robot SSI Mantra’s Hallowed NASDAQ Moment in New York

New Delhi: It was a hallowed moment of pride for surgical robot SSI Mantra, its architect and robotic surgery wizard Dr Sudheer Srivastava, entire Indian Medtech Industry and ‘Make in…

  • Pharma
  • June 4, 2025
  • 119 views
Zydus to acquire 2 biologics manufacturing units in U.S. from Agenus for $125 million

Zydus Lifesciences plans to acquire Nasdaq-listed clinical-stage immuno-oncology firm Agenus’s two biologics manufacturing facilities in California, U.S. for $125 million to enter the global biologics contract development and manufacturing organization…

  • Pharma
  • June 3, 2025
  • 143 views
Ananda Pharma advances CBD drug with Phase 1 study listing

LONDON –  Ananda Pharma PLC (AQSE:ANA), a UK-based biopharmaceutical company, has announced the publication of its Phase 1 pharmacokinetic study on the clinical trial registry clinicaltrials.gov, with the reference number…

With Advent of Level Playing Field, Domestic MedTech Industry exclaims ‘Eureka!’

AiMed showers unqualified praise on Government for jettisoning foreign favoritism New Delhi: Rajiv Nath, one of the greatest champions of Make in India and no nonsense leader of domestic medical…

Govt supports indigenous manufacturing of complex pharma excipients by Nitika Pharmaceutical Specialties

For commercial-scale production of 14 complex excipients The Technology Development Board (TDB), Department of Science and Technology (DST), Government of India has extended financial support to Nitika Pharmaceutical Specialties Private…

  • Pharma
  • June 3, 2025
  • 174 views
Medical representatives barred from govt hospitals to stop pharma influence

Medical representatives will no longer be permitted to meet doctors directly within central government hospitals, following a directive from the Centre aimed at putting an end to the nexus between…

  • Pharma
  • May 31, 2025
  • 314 views
Generic drugs can bring hope for SMA patients’

Dr Ann Agnes Mathew, a consultant paediatric neurologist and neuromuscular specialist based in Bengaluru, treats nearly 600 SMA patients from across India. In an interview with DH’s Udbhavi Balakrishna, she…

  • Pharma
  • May 31, 2025
  • 294 views
47% of pharma MOUs from VGGS 2024 commissioned

Gandhinagar:  The state govt said that 47% of MoUs signed in the pharmaceutical sector in the Vibrant Gujarat Global Summit (VGGS) 2024 have been commissioned. It said on Friday that…

  • Pharma
  • May 30, 2025
  • 263 views
I-Sec downgrades Aurobindo Pharma to Add, target price Rs 1,330

ICICI Securities has downgraded Aurobindo Pharma to Add (from Buy earlier) with a revised target price of Rs 1,330 (earlier Rs 1,445). The current market price of Aurobindo Pharma Ltd.…

  • Pharma
  • May 30, 2025
  • 102 views
AstraZeneca gets CDSCO nod for lung cancer drug

New Delhi:  AstraZeneca India Pharma on Thursday said it has received approval from the government authority for the import, sale, and distribution of a medication used in treating non-small cell…

  • Pharma
  • May 29, 2025
  • 292 views
Anar Modi named CHO at Senores Pharma

Senores Pharma has named Anar Modi as the Chief Heart Officer (CHO) of its group. The announcement was made through a LinkedIn post, where the company stated, “We’re excited to…

  • Pharma
  • May 29, 2025
  • 294 views
Natco Pharma Q4 Results: Profit Misses Estimates, Margin Contracts; FY26 Outlook Gloomy

Natco Pharma Ltd. reported slower-than-expected earnings growth in the final quarter of FY25 as it prepares for a turbulent new year due to Trump’s tariff policies. Consolidated net profit rose…

  • Pharma
  • May 28, 2025
  • 281 views
Cops bust inter-state pharma drug cartel, nab 5

The Delhi Police have busted an inter-state cartel operating across Delhi, Uttar Pradesh and Himachal Pradesh, arresting five key traffickers and seizing over 32,000 tablets of controlled substances, an official…

  • Pharma
  • May 28, 2025
  • 285 views
1,787 abortion kits seized, 6 FIRs filed after raids in Haryana last week

Chandigarh, Authorities in Haryana has seized 1,787 Medical Termination of Pregnancy kits during statewide inspections carried out last week to check their illegal sale, and registered six FIRs in this…

  • Pharma
  • May 27, 2025
  • 268 views
Stock market update: Nifty Pharma index advances 0.11%

NEW DELHI: The Nifty Pharma index closed on a positive note on Tuesday. Shares of Granules India Ltd.(up 1.7 per cent), Laurus Labs Ltd.(up 1.14 per cent), Mankind Pharma Ltd.(up…

  • Pharma
  • May 27, 2025
  • 380 views
Amrut Medhekar to exit Akums Drugs and Pharma as CEO-CDMO Business

New Delhi:  Akums Drugs and Pharma has announced the resignation of Amrut Medhekar, CEO- CDMO Business of the Company effective July 15 to pursue new opportunities and challenges. “In terms…